Company intelligence / Profile preview

LIDE Biotech

Shanghai, Shanghai, Chinalidebiotech.com ↗
Ownership
Private
Employees
~51
Development stage
Commercial
01

Overview

LIDE Biotech provides advanced preclinical contract research services with a focus on oncology. Their offerings include over 2000 patient-derived xenograft (PDX) models across more than 50 cancer types—including drug-resistant/genetically altered variants—MiniPDX rapid efficacy testing platform delivering results in seven days, conditionally reprogrammed cell lines maintaining tumor heterogeneity, CDX models for cost-effective in vivo studies, comprehensive omics/bioanalysis capabilities (genomics/transcriptomics/proteomics), and robust immuno-oncology model systems. The company has delivered thousands of projects globally over its 12-year history[1][2][4][5].

Therapeutic areas
Oncology
Modalities
AntibodyAntibody-drug conjugateCell therapyOncolytic virus therapySmall moleculePeptides
Industry
Drug Discovery Services
02

Partnerships

Academic institutions/KOLs globallysmall biotech companies & multinational pharmaceutical organizations for outsourced R&D projects

Beyond the preview

Go deeper on LIDE Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIDE Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call